Government Amends Drug Rules to Strengthen Regulation of High Alcohol Content Medicines

Why in News?

• The Union Ministry of Health and Family Welfare has amended the Drugs Rules, 1945 to strengthen regulatory oversight of medicinal formulations containing high concentrations of ethyl alcohol. 
• The move aims to prevent misuse of such products for intoxication while ensuring their availability for genuine medical purposes.

What Has Changed?

• The government has withdrawn the licensing exemption previously available under Schedule K for certain medicinal formulations containing high levels of ethyl alcohol.
• Earlier, several products such as cardamom tincture, ginger tincture, and other aromatic medicinal preparations were exempt from licensing requirements.
• Under the new rules, all medicinal formulations containing more than 12% v/v ethyl alcohol in quantities exceeding 30 ml will require a valid licence under the Drugs and Cosmetics Act, 1940.

Why Was the Amendment Needed?

• Some exempted medicinal formulations contain 80-90% v/v ethyl alcohol, making them vulnerable to misuse as intoxicating substances.
• Several State governments had raised concerns regarding the diversion and misuse of these products.
• The amendment seeks to strengthen control over the manufacture, distribution, and sale of such formulations.

Shift to Schedule H1

• The amended rules also place these high-alcohol formulations under Schedule H1 of the Drugs Rules, 1945.
• This means:
• They can be sold only on the prescription of a registered medical practitioner.
• Pharmacies must maintain strict sales records as required under Schedule H1. 
• Regulatory monitoring of these products will become more stringent.

Expected Benefits

• The amendment is expected to:
  • Prevent the misuse and illegal diversion of medicinal products containing high alcohol content.
  • Ensure that such medicines are available only through the regulated pharmaceutical supply chain.
  • Promote the safe and rational use of medicines.
  • Strengthen India's drug regulatory framework and protect public health.

What are the Drugs Rules, 1945?

• The Drugs Rules, 1945 are a set of rules framed by the Government of India under the Drugs and Cosmetics Act, 1940 to regulate the manufacture, import, distribution, sale, labelling, storage, and quality control of drugs and cosmetics in India.

Objectives

• Ensure the quality, safety, and efficacy of drugs and cosmetics.
• Regulate the licensing of manufacturers, wholesalers, and retailers.
• Prevent the manufacture and sale of substandard, adulterated, or misbranded drugs.
• Promote the safe and rational use of medicines.
• Protect public health through effective regulation of pharmaceuticals.

Key Features

• Prescribes licensing requirements for manufacturing and sale of drugs.
• Specifies standards for packaging, labelling, and storage of medicines.
• Classifies medicines into different Schedules (such as Schedule H, H1, X, K, etc.), each with specific regulatory requirements.
• Lays down rules for prescription drugs, controlled substances, biological products, vaccines, and medical devices.
• Empowers drug inspectors and licensing authorities to enforce compliance.

Important Schedules under the Drugs Rules, 1945

Drugs and Cosmetics Act, 1940

The Drugs and Cosmetics Act, 1940 is the primary legislation in India that regulates the import, manufacture, distribution, sale, and quality of drugs, cosmetics, and certain medical devices. It aims to ensure that medicines and cosmetics available in the country are safe, effective, and of standard quality, thereby protecting public health.

Objectives

• Ensure the safety, efficacy, and quality of drugs and cosmetics.
• Prevent the manufacture and sale of spurious, adulterated, and misbranded products.
• Regulate the import, manufacture, sale, and distribution of drugs and cosmetics.
• Establish uniform standards for drugs and cosmetics across India.
• Protect consumers from unsafe or substandard medical products.

Key Features

• Provides the legal framework for regulating drugs, cosmetics, blood products, vaccines, and certain medical devices.
• Empowers the Central and State Governments to issue licences and enforce compliance.
• Prescribes penalties for offences such as manufacturing or selling counterfeit or substandard drugs.
• Establishes standards for testing through government laboratories.
• Enables appointment of Drug Inspectors to inspect manufacturing units and retail outlets.

Regulatory Authorities

• Central Drugs Standard Control Organisation (CDSCO): India's national drug regulatory authority responsible for approval of new drugs, clinical trials, and regulation of imports.
• State Drug Control Departments: Responsible for licensing and monitoring the manufacture and sale of drugs and cosmetics within their respective States.

Prelims Practice MCQs

Frequently Asked Questions (FAQs)